91 related articles for article (PubMed ID: 20850706)
1. A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression.
Ough M; Velasco J; Hieken TJ
Am J Surg; 2011 May; 201(5):692-4. PubMed ID: 20850706
[TBL] [Abstract][Full Text] [Related]
2. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer.
Park SY; Kim KS; Lee TG; Park SS; Kim SM; Han W; Noh DY; Kim SW
Am J Surg; 2009 Feb; 197(2):266-9. PubMed ID: 18614146
[TBL] [Abstract][Full Text] [Related]
3. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy.
Rao R; Lilley L; Andrews V; Radford L; Ulissey M
Ann Surg Oncol; 2009 May; 16(5):1170-5. PubMed ID: 19263171
[TBL] [Abstract][Full Text] [Related]
4. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?
Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ
Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.
Shah VI; Flowers CI; Douglas-Jones AG; Dallimore NS; Rashid M
Histopathology; 2006 May; 48(6):683-91. PubMed ID: 16681684
[TBL] [Abstract][Full Text] [Related]
6. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen.
Monticciolo DL
Breast J; 2005; 11(1):9-14. PubMed ID: 15647072
[TBL] [Abstract][Full Text] [Related]
7. Assessment of microvessel density in core needle biopsy specimen in breast cancer.
Rydén L; Boiesen P; Jönsson PE
Anticancer Res; 2004; 24(1):371-5. PubMed ID: 15015623
[TBL] [Abstract][Full Text] [Related]
8. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasound-guided core needle biopsy in the diagnosis of breast lesions].
Fan ZQ; Ouyang T; Wang TF; Li JF; Xie YT; Fan T; Zhang Z; Lin BY
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1185-7. PubMed ID: 18067713
[TBL] [Abstract][Full Text] [Related]
10. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy.
Usami S; Moriya T; Amari M; Suzuki A; Ishida T; Sasano H; Ohuchi N
Jpn J Clin Oncol; 2007 Apr; 37(4):250-5. PubMed ID: 17485439
[TBL] [Abstract][Full Text] [Related]
11. Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement.
van de Ven SM; Lin MC; Daniel BL; Sareen P; Lipson JA; Pal S; Dirbas FM; Ikeda DM
J Magn Reson Imaging; 2010 Jul; 32(1):101-9. PubMed ID: 20575077
[TBL] [Abstract][Full Text] [Related]
12. Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy.
Khoury T; Zakharia Y; Tan W; Kulkarni S; Liu W; Zhang S; Wilding GE; Edge S
Breast J; 2011; 17(2):180-6. PubMed ID: 21306471
[TBL] [Abstract][Full Text] [Related]
13. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
14. Modified core wash cytology (CWC), an asset in the diagnostic work-up of breast lesions.
Wauters CA; Sanders-Eras MC; de Kievit-van der Heijden IM; Wesseling P; Venderink DJ; van Dijk Azn R; van den Wildenberg F; Kooistra BW; Strobbe LJ
Eur J Surg Oncol; 2010 Oct; 36(10):957-62. PubMed ID: 20708371
[TBL] [Abstract][Full Text] [Related]
15. Assessment of pathologic prognostic factors in breast core needle biopsies.
Sharifi S; Peterson MK; Baum JK; Raza S; Schnitt SJ
Mod Pathol; 1999 Oct; 12(10):941-5. PubMed ID: 10530557
[TBL] [Abstract][Full Text] [Related]
16. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
17. Biopathologic profile of breast cancer core biopsy: is it always a valid method?
Cavaliere A; Sidoni A; Scheibel M; Bellezza G; Brachelente G; Vitali R; Bucciarelli E
Cancer Lett; 2005 Jan; 218(1):117-21. PubMed ID: 15639347
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
19. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy.
Cahill RA; Walsh D; Landers RJ; Watson RG
Ann Surg Oncol; 2006 Jan; 13(1):45-51. PubMed ID: 16378157
[TBL] [Abstract][Full Text] [Related]
20. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions.
Klevesath MB; Godwin RJ; Bannon R; Munthali L; Coveney E
Eur J Surg Oncol; 2005 Jun; 31(5):490-4. PubMed ID: 15922884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
